Altium Capital (AC) is an investment fund started by Jacob Gottlieb. AC look to make investments in growing companies who are in the healthcare industry. AC is not the first investment fund that Gottlieb founded. He was also able to create a hedge fund called Visium Asset Management (VSA). He created Balyasny Asset Management, L.P. AC have invested in several healthcare companies such as Oramed Pharmaceuticals (ORMP), Amarin Corporation (AMRN) as well as Oragenics. Gottlieb earned an Economics degree from Brown University, and he has held positions as an analyst and portfolio manager. His finance expertise was gained while working at Sanford C. Bernstein & Co., LLC, and Merlin BioMed Group.
In 2005, Gottlieb started the hedge fund VSA. By 2016, the fund had grown to over $8 billion. VSA had an insider-trading scandal, but Gottlieb was not involved in the scandal. He has studied medicine at New York University School of Medicine. Gottlieb learned as an analyst at Sanford C. Bernstein & Co., LLC about the healthcare industry. ORMP is a company that developed an insulin pill. It is a more affordable method for diabetics who had drug administered via injection. The insulin pill has not been approved by the FDA. AMRN develops drugs that will help with cardiovascular health. The company is known for a drug called Vascepa. Vascepa gained approval by the FDA 2012, and it was omega-3 fatty acid that required a prescription. Oragenics work in replacement therapy. Replacement therapy replaces harmful bacteria with bacteria that provide benefits to the body. Oragenics fights diseases that occur in the throat and esophagus.
Gottlieb using his time and money to help with philanthropic projects. He has been able to raise millions that help the education of the youth. There are many non-profit organizations such as The Windward School and East Harlem Tutorial Program that benefits Gottlieb’s philanthropy.
Find out more about Jacob Gottlieb: https://www.crunchbase.com/organization/altium-capital